MedPath

Ocular Imaging Study Using Advanced OCT

Conditions
Macular Degeneration
Retinal Vascular Disorder
Registration Number
NCT02827071
Lead Sponsor
University of California, Los Angeles
Brief Summary

The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if this imaging device and software can improve the quality of images and visualization of imaged tissues and whether they are useful in the diagnosis and treatment of eye diseases. Images collected in this study may be compared to other images collected as part of standard of care on the same patient (OCT, FA, AF, Fundus).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria

• Any patient with abnormal retinal findings as determined by investigators.

Read More
Exclusion Criteria
  • Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging.
  • Participants who are unable to maintain retinal fixation on a specified target.
  • Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place.
  • Patients with media opacity which preclude high quality imaging.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Retinal vascular abnormalities imaged by OCT Angiography and en face analysis of macular disorders2 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stein Eye Institute/Geffen School of Medicine

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath